TriGemX Bio
TriGemX Bio uses the science of gut-brain biology to create medicines that transform human health.
TriGemX Bio raised $94M in a funding round announced October 1, 2026, according to businesswire.com. Investors in that round: TCG Crossover, The Column Group, Viking Global Investors.
Founders and team
- ARAlex Rives Foundersource: crunchbase.com
- CZCharles Zuker Foundersource: crunchbase.com
- RARichard Axel Foundersource: crunchbase.com
- TMThomas Maniatis Foundersource: crunchbase.com
- NTNancy Thornberry Member, Board of Directors and Chair, R&Dsource: crunchbase.com
- AKAnita Kawatra EVP, Corporate Affairssource: crunchbase.com
- BLBrett Lauring Chief Medical Officersource: crunchbase.com
- CCCariad Chester Board membersource: crunchbase.com
- FSFernando Salles Chief Business Offciersource: crunchbase.com
- JGJay Galeota President & Chief Executive Officersource: crunchbase.com
- JGJeff Goater Board membersource: crunchbase.com
- JWJosh Wolfe Board membersource: crunchbase.com
- PFPatrick Flanigan III Chief Financial Officersource: crunchbase.com
- PMPeter M. Hecht Board membersource: crunchbase.com
- SPShirly Pinto Chief Scientific Officersource: crunchbase.com
Raise history
- Round · $94MSource: businesswire.com
Investors
BBill & Melinda Gates Foundation
BBill Gates
CCasdin Capital
- EEuclidean Capital
PPolaris Partners
TTao Capital Partners
TTCG Crossover
TThe Column Group
VViking Global Investors
Related bio health companies
SSedMed$4M · Oct 1, 2026
SSharp$328K · Oct 1, 2026MM-BasedOct 1, 2026
AAyna HealthOct 1, 2026BBiotia$9M · Oct 1, 2026
VVytalYou$830K · Sep 30, 2026
LLindera USSep 29, 2026
OOrtet$500M · Sep 29, 2026
Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/trigemx-bio.